Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Completed

• Conditions: Emergencies
• Interventions: Other: RECOP unit patient

• Registration Number: NCT04422587
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

This research aims to improve our knowledge of the epidemiology of patients consulting in the COvid-19 Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID-19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out.

A central issue of this diagnostic strategy will be to be rapid, since the diagnosis will have to be made in the context of significant flows, with a need to quickly refer patients to the most suitable downstream service, while limiting the risk contamination of caregivers and vulnerable patients if a COVID-19 + patient is admitted to an unsuitable service. However, virological tests do not currently allow rapid results for COVID-19.

Research project of investigatory aims to develop a predictive model of the risk of being COVID-19 positive for patients admitted to the emergency room for acute dyspnea.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-13
• Primary Completion: 2020-06-05
• Study First Submitted: 2020-06-05
• Study Completion: 2020-06-07
• Study First Submitted QC: 2020-06-08
• Study First Posted: 2020-06-09
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-04
• Last Update Posted: 2020-11-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1860

Inclusion Criteria

• All patients over 15 years admitted to the RECOP unit for dyspnea

Exclusion Criteria

• Patient admitted to shock for respiratory distress requiring immediate respiratory support.
• Patient under justice safeguard

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
RECOP unit patient	RECOP unit patient	All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified.

Primary Outcome Measures

Name	Time	Method
Develop a predictive model of the risk of being COVID-19 for patients admitted to the emergency room for dyspnea	inclusion day	demographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor

Secondary Outcome Measures

Name	Time	Method
Mortality status	30 days	Mortality status will be collected by a phone call at the patient
Describe the characteristics of patients admitted to reCOP units according to their virological status	30 days	The COVID-19 virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking
Virological status	30 days	Virological status will be collected by a phone call at the patient

Trial Locations

Locations (1)

University Hospital of Toulouse; 🇫🇷 Toulouse, France